ABSTRACT: Prolonged microgravity experienced by astronauts is associated with a decrease in bone mineral density. To investigate the effect of microgravity on differentiation of osteoclasts and osteoblasts, we used a NASA-recommended, ground-based, microgravity-simulating system, the Rotary Cell Culture System (RCCS). Using the RCCS, we demonstrated that modeled microgravity (MMG) inhibited osteoblastogenesis and increased adipocyte differentiation in human mesenchymal stem cells incubated under osteogenic conditions. This transformation involves reduced RhoA activity and cofilin phosphorylation, disruption of F-actin stress fibers, and decreased integrin signaling through focal adhesion kinase. We have used the system to show that MMG also stimulates osteoclastogenesis. These systems provide the opportunity to develop pharmacological agents that will stimulate osteoblastogenesis and inhibit osteoclastogenesis.
INTRODUCTION
Microgravity experienced by astronauts during spaceflights causes severe physiological alterations in the human body. The decrease in bone mineral density is one of the most important of these problems, the severity of which appears to correlate with flight duration. 1 It has been determined that 1-2% of bone mass is lost every month during spaceflight and this loss is site specific occurring mostly in the weight-bearing bones. 2 Several independent studies have detected decreases in osteoblastic markers of bone formation both in vivo and in vitro, which contribute substantially to the observed bone loss in microgravity. 3, 4 An increase in bone resorption markers, including urinary calcium levels and collagen cross-links in astronauts during 6 months' spaceflight, has been reported. 5 The underlying molecular mechanisms responsible for the apparent concurrent decrease in bone formation and increase in bone resorption are unknown.
MODELED MICROGRAVITY (MMG): ROTARY CELL CULTURE SYSTEM (RCCS) SIMULATES MICROGRAVITY
Due to payload constraints, flight frequency and cost, spaceflight experiments are limited. Therefore, NASA has developed a ground-based system that is able to simulate microgravity. It is referred to as the RCCS and, the "microgravity" created by it is referred to as modeled microgravity (MMG). The rotational motion of the system prevents sedimentation, creating an optimized suspension culture capable of supporting three-dimensional cell growth on microcarrier bead scaffolds. 6 The high aspect ration vessels (HARVs) used in the RCCS provide two essential components of the optimized suspension cell culture system-first is the solid body rotation and second is the diffusionmediated oxygenation. Solid body rotation of the media and microcarrier beads with attached cells allows minimal shear stress and mechanical damage to the cells. Oxygenation occurs as a result of a silicon membrane that allows appropriate diffusion of gases preventing hypoxic conditions and turbulenceinducing air space or bubbles. 7 We have used the RCCS to study both osteoblastogenesis and osteoclastogenesis. These studies support the hypothesis that both decreased osteoblastogenesis and increased osteoclastogenesis lead to bone loss in MMG environment.
MMG INHIBITS OSTEOBLASTOGENESIS AND STIMULATES ADIPOGENESIS IN HUMAN MESENCHYMAL STEM CELLS
To study osteoblastogenesis, human mesenchymal stem cells (hMSC) were used. The hMSC in osteogenic media in vitro under normal gravity, differentiate into osteoblasts capable of matrix mineralization. 8 Human MSC (10 6 ) were cultured on microcarrier beads for 7 days in DMEM with 10% fetal bovine serum (FBS). Cells were then transferred to HARVs for MMG or culture plates for gravity (G) control. Osteogenic differentiation was induced (media supplemented with 10 nM dexamethasone, 10 mM ␤-glycerophosphate, and 50 M ascorbic acid-2-phosphate) immediately before transferring into MMG and G. HARVs were rotated to reach a state of solid body rotation (cell-beads aggregates in suspension) and medium was changed every 3 days. Cells were harvested 7 days after the initiation of MMG and processed for mRNA and protein extraction. 9 RT-PCR analysis showed that MMG inhibited the expression of osteoblastogenesis markers, alkaline phosphatase, collagen type I, osteocalcin, and the FIGURE 1. MMG enhances TRAP expression. RAW264.7 cells were incubated with microcarrier beads in MMG or G for 24 h. Cells were separated from beads and plated at normal gravity. After incubation with 20 ng/ml RANKL for 3 days RNA was extracted followed by RT-PCR for TRAP and GAPDH. osteogenic transcription factor Runx2 and stimulated the expression of adipogenic markers adipsin, leptin, and glut 4 along with an increase in the adipogenic transcription factor PPAR␥ . 9 The underlying signaling mechanism involves reduced RhoA activity that leads to disruption of the cytoskeleton, which is mediated by decrease in phosphocofilin. Reduction in RhoA is associated with altered integrin signaling that leads to decreases in phospho-FAK, Ras-GTP, and phospho-ERK, ultimately resulting in the inhibition of osteoblastogenesis as determined by Western blot analysis of bone-specific markers.
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MMG STIMULATES OSTEOCLASTOGENESIS IN RAW264.7 CELLS
A unique system has recently been developed to study osteoclastogenesis in the MMG environment. Cells from the murine macrophage cell line RAW264.7 were used. RAW264.7 cells (2 × 10 6 ) cultured in DMEM complete media containing 10% FBS were initially incubated with 100 mg microcarrier beads at 37
• C overnight. Cells were attached around the circumference of beads. Beads with cells attached were put into 10 mL fresh complete DMEM and then placed in the rotating bioreactor located in an incubator at 37
• C and 5% CO 2 and allowed to rotate at 9 rpm (speed previously determined by using fluorescent beads so that they remain in suspended position). Parallel bead-attached cells were cultured in gravity. The pH, pO 2 , and pCO 2 were unchanged in the RCCS; thus the apparatus did not affect the oxygenation status or pH compared to gravity (G). RAW264.7 cells attached to beads incubated in MMG or G for 24 h were separated from beads and seeded on plates at normal gravity. Cells were then incubated with 20 ng/ml RANKL for 3 days. RT-PCR (FIG. 1) and real-time PCR (data not shown) showed that TRAP expression was enhanced in 24 h MMG-treated cells as compared to the G cells after RANKL treatment. After 4 days of RANKL treatment, multinucleated TRAP-positive FIGURE 2. MMG enhances osteoclastogenesis. RAW264.7 cells were incubated with microcarrier beads in MMG or G for 24 h, then separated from beads and plated in 6-well plates. These cells were stimulated with 20 ng/mL RANKL. On day 4, the number of multinucleated osteoclasts from MMG and G cells were counted in several fields using the microscope.
osteoclasts derived from 24 h MMG-treated cells were increased approximately twofold compared to those from gravity-treated cells (FIG. 2) . The sensitivity of MMG-treated cells to RANKL induction of osteoclastogenesis was increased (data not shown).
In summary, MMG leads to decreased osteoblastogenesis and increased adipogenesis in hMSC via disruption of stress fibers and altered integrin signaling, which are likely mediated by a decrease in RhoA. MMG also stimulates RANKL-mediated osteoclastogenesis in RAW264.7 cells as compared to gravity controls. These results are analogous to those obtained in humans on long duration spaceflights. Also, the bone loss associated with microgravity is similar to that induced on Earth by inactivity. 12 Therefore, these in vitro systems present a unique opportunity to investigate not only the molecular mechanisms but also test potential pharmacological agents for preventing bone loss associated with microgravity in space and disuse osteoporosis on Earth.
